Related Experiment Video
Updated: Aug 7, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by
Cornelia Cudrici1, Teodora Niculescu, Florin Niculescu
1Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. It is mediated by activated lymphocytes, macrophages, microglia, and complement. In MS, myelin-forming oligodendrocytes (OLGs) are the targets of inflammatory and immune attacks. OLG death by apoptosis or necrosis causes the cell loss seen in MS plaques. Studies of experimental allergic encephalomyelitis (EAE) in caspase 11-deficient mice show that caspase-mediated death of OLGs is critical to demyelination. Complement activation may affect MS pathogenesis through activated terminal complex C5b-9, which promotes demyelination, and through sublytic C5b-9, which protects OLGs from apoptosis. By inducing EAE in C5-deficient mice, we showed that complement C5 promotes axon preservation and new myelin formation, which protect OLGs from apoptosis. These findings indicate that activated complement C5b-9 plays a proinflammatory role in acute MS but may also protect OLGs from death in chronic MS.
Insights
Multiple sclerosis involves immune attacks on oligodendrocytes. Complement C5b-9 promotes demyelination in acute MS but may protect these cells in chronic stages.
Area of Science:
- Neuroimmunology
- Demyelinating Diseases
Background:
- Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
- Immune cells and complement system mediate attacks on myelin-forming oligodendrocytes (OLGs).
- OLG death contributes to demyelination and cell loss in MS plaques.
Purpose of the Study:
- To investigate the role of complement activation in oligodendrocyte death and demyelination in MS.
- To elucidate the dual role of complement C5b-9 in acute versus chronic MS pathogenesis.
Main Methods:
- Studies utilized experimental allergic encephalomyelitis (EAE) models in mice.
- Experiments involved caspase 11-deficient and C5-deficient mice.
- Analysis of oligodendrocyte apoptosis, necrosis, and demyelination.
Main Results:
- Caspase-mediated OLG death is critical for demyelination in EAE.
- Complement C5b-9 promotes demyelination via the terminal complex.
- Sublytic C5b-9 protects OLGs from apoptosis, while C5 promotes axon preservation and remyelination.
Conclusions:
- Activated complement C5b-9 has a dual role in MS pathogenesis.
- C5b-9 is proinflammatory in acute MS, contributing to demyelination.
- C5b-9 may offer protection against OLG death in chronic MS through promoting remyelination.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Apoptosis
Multiple Sclerosis l: Introduction
Cellular Injury V: Apoptosis and Autophagy
